Editor’s highlights from the Journal of Comparative Effectiveness Research – May 2020
Peek behind the paper: is high-dose baclofen use associated with increased risk of encephalopathy in individuals with chronic kidney disease?
Editor’s highlights from the Journal of Comparative Effectiveness Research – April 2020
[ON DEMAND] Improving efficiency in health technology assessment with advanced software: a panel discussion
Utilizing real-world data to inform healthcare decision making during the COVID-19 pandemic: an interview with Daniel Prieto-Alhambra
The relevance of registry and real-world data during the COVID-19 pandemic: an interview with Philip Robinson
Estimating the opportunity–cost-based cost–effectiveness threshold: a peek behind the podcast
Social distancing and self-isolation 100 years after the 1918 influenza pandemic: what have we learnt from pandemics of the past?
Assessment-schedule matching in unanchored, indirect treatment comparisons of progression-free survival in cancer studies
Look behind the lecture: can biosimilars improve patient access in countries with restricted resources?
The use of simulated and indirect treatment comparison methods to evaluate therapies’ comparative effectiveness: an interview with Gabriel Tremblay
Patient-reported outcomes in health technology assessment: an interview with Olivier Chassany
Editor’s highlights from Future Oncology – February 2020